EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Verrica Pharmaceuticals Inc.
VRCA

VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. · NASDAQ
Market Open
4.14
▼ ⁦-1.66%⁩ (-0.07)
Market Cap$72.3M
Beta1.50
52w Low52w High
3.289.82
Last Week
⁦-7.17%⁩
Last Month
⁦-21.89%⁩
Last 3 Months
⁦-30.30%⁩
Last Year
⁦-0.96%⁩
EL7 Factor Analysis
How we score this
Overall16
Poor — bottom quartile of the marketSucker StockF 7/9DistressInsider cluster buyBetter than 16% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
29
—17.4xBottom tier
▸
Growth
95
106.2%▲7.1%Top tier
▸
Quality
47
-209.9%▼4.5%Around median
▸
Safety
13
—2.6xBottom tier
▸
Capital Return
31
0.00%▼0.18%Bottom tier
▸
Momentum
37
31.1%▲1.3%Bottom tier
▸
Sentiment
90
33Top tier

Frequently Asked Questions

What is Verrica Pharmaceuticals Inc. stock?▼

Verrica Pharmaceuticals Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Verrica Pharmaceuticals Inc.?▼

You can buy Verrica Pharmaceuticals Inc. shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Verrica Pharmaceuticals Inc.?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Verrica Pharmaceuticals Inc. pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Verrica Pharmaceuticals Inc.?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

Compare in the screener

AI analysis from the earnings call, financials and news

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 1 analysts setting price target
$9.00
⁦+117.4%⁩
Current Price $4.14·Median $9.00
Low
$9.00
High
$9.00
Street summary

Verrica Pharmaceuticals Price Target Revision

The price target for Verrica stock has seen a sharp decline of 32.08% over the past thirty days, with the consensus dropping from $13.25 to $9. This adjustment reflects a fundamental reassessment of fair value, despite Lake Street initiating coverage on the stock with a 'Buy' rating on August 27, 2026. The current price target of $9 remains above the market price ($5.36), yet this significant reduction indicates a lowering of previous expectations.

As of 2026-09-03
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 3.86
Buy
Analyst coverage
7
Buy conviction
86%
High
Target dispersion
0%
Analyst ratings over time7 analysts rating
6
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.83 → 3.86
Recent analyst moves
  • = Reiterate2026-08-27
    Lake Street
    Buy
  • = Reiterate2026-01-07
    TD Cowen
    Buy
  • = Reiterate2025-12-18
    Loop Capital Markets
    —· $17.00
Premium content
Financial Analysis
|